Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011525795-A |
titleOfInvention |
Biomarkers and related methods for patient selection |
abstract |
The present invention relates to a method of eliciting an immune response against an antigen in a patient by administering an immunogenic composition for the treatment of a human disease, the patient being selected from a patient population of interest. The invention further relates to a method for determining whether a subject is prone to develop a prophylactic or therapeutic immune response after such treatment. |
priorityDate |
2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |